Pharma Journalist -

SunGen Pharma announced it has received its sixth ANDA approval from the US Food and Drug Administration (FDA). The sixth approved ANDA is for Methylprednisolone tablets, 4 mg. This…
Read More...

Ligand Pharmaceuticals Incorporated and SQ Innovation AG announced that the two companies have entered into long-term, exclusive commercial license and supply agreements for use of…
Read More...

SMi’s inaugural Highly Potent Active Pharmaceutical Ingredients USA Conference, will focus on the latest innovative manufacturing technologies with a special spotlight presentation on…
Read More...

BeiGene, Ltd. announced that the China National Medical Products Administration (NMPA, formerly known as the CFDA) has granted priority review status to the supplemental new drug…
Read More...

Grifols announced that Xembify, its new 20% subcutaneous immunoglobulin, has been approved by the U.S. Food and Drug Administration (FDA). Xembify is used to treat primary…
Read More...

SMi Reports: Senior experts from Optima and Optima Pharma to lead a post-conference workshop during Lyophilization USA, convening October 23rd to 24th 2019 Delegates for the 5th…
Read More...

Confo Therapeutics, an emerging drug discovery company, and DyNAbind GmbH announce a drug discovery collaboration on an undisclosed G-protein coupled receptor (GPCR). The…
Read More...

Roche announced that the phase III MINISTONE-2 study met its primary endpoint, demonstrating that Xofluza (baloxavir marboxil) was well tolerated in children with flu. The study also…
Read More...

GSK announced the start of a phase III clinical development programme with otilimab, an investigational anti-granulocyte macrophage colony-stimulating factor (anti GM-CSF) monoclonal…
Read More...

Telix Pharmaceuticals Limited, a clinical-stage biopharmaceutical company focused on the development of diagnostic and therapeutic products based on targeted radiopharmaceuticals or…
Read More...